Back to Top

Nicholas Cheng provides an overview of his study on identifying early cancer biomarkers in pre-diagnosis blood samples collected from more than 400 OHS participants. He demonstrates how blood signatures can be used to detect breast, prostate and pancreatic cancers years prior to clinical detection using cfDNA methylation profiles. Kimberly Skead describes her work studying how the interacting

Dr. Philip Awadalla, (National Scientific Director, CanPath; Executive Scientific Director, Ontario Health Study) discusses how data from large population health cohorts like CanPath can be harnessed to support research into COVID-19 such as the socioeconomic and mental health impact, as well as disease severity, infection rates, and mapping of where people are most likely to

A University of Calgary epidemiologist is using data from Ontario Health Study (OHS) participants to explore how environmental or lifestyle factors could be associated with breast cancer in younger women. Dr. Darren Brenner recently gained approval to study the de-identified data for female participants who were ages 35 to 50 and cancer-free at the time they